|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
28 November 2022 |
|
Main ID: |
NCT03531086 |
|
Date of registration:
|
08/05/2018 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Idiopathic Parkinson's Progression and Dopamine Transporter SPECT
|
|
Scientific title:
|
Exploring Dopamine Transporter Single-photon Emission Computer Tomography Quantification as a Measure of Disease Progression in Idiopathic Parkinson's Disease |
|
Date of first enrolment:
|
January 19, 2018 |
|
Target sample size:
|
12 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03531086 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Julie Gurwell, PhD, PA-C |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Kentucky |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Between the ages of 40-75
- Able to give informed consent
- Show a positive response to carbidopa/levodopa
- Hoehn and Yahr score 1-3
Exclusion Criteria:
- Under the age of 40 or over the age of 75
- Unable to give informed consent
- Nonresponsive to carbidopa/levodopa
- Hoehn and Yahr score 4-5
- Unable to discontinue medications which might interfere with DaTscan TM imaging
- Inability to lie still for 30-45 minutes during CT-SPECT imaging
- Pregnancy or Nursing
- Severe kidney function impairment
- Unable to tolerate iodine containing products
- Patients with deep brain stimulation (DBS) or a history of any other brain surgery
Age minimum:
40 Years
Age maximum:
75 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Parkinson Disease
|
|
Intervention(s)
|
|
Drug: Ioflupane I 123
|
|
Primary Outcome(s)
|
|
Change in dopamine transporter binding in idiopathic Parkinson's Disease progression.
[Time Frame: 1-year]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|